Capula Management LTD Edwards Lifesciences Corp Transaction History

Capula Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $510,201 - $653,176	7,470 Added 137.06%	12,920 $963,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $448,916 - $584,730	5,450 New	5,450 $450,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $864,788 - $1.06 Million	-8,130 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $544,188 - $649,102	5,288 Added 186.07%	8,130 $920,000
Q2 2021 Aug 13, 2021	BUY	$83.84 - $104.76 $238,273 - $297,727	2,842 New	2,842 $294,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.